Hodgkin Lymphoma Clinical Trials

Find Hodgkin Lymphoma Clinical Trials Near You

Feasibility of High Intensity Interval Training in Survivors of Childhood, Adolescent, and Young Adult Hodgkin Lymphoma

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Objective: To determine the feasibility of a 12-week high intensity interval training (HIIT) program in survivors of childhood, adolescent, and young adult Hodgkin lymphoma within 24 months of completing treatment. Feasibility will be assessed by: * Participation Rate: Number of eligible survivors approached who enroll. * Completion Rate: Number of scheduled HIIT sessions attended and number of enrolled participants who complete post-intervention testing.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 10
Maximum Age: 25
Healthy Volunteers: f
View:

• Participant has been diagnosed with Hodgkin lymphoma between the ages of 10 to 25 years.

• Participant is between the ages of \>10 and \<25 years old the time of enrollment.

• Participant has completed treatment (end of chemotherapy for those not receiving radiation therapy or end of radiation therapy) for Hodgkin lymphoma within 24 months prior to enrollment and recovered from any acute treatment-related adverse events.

• Participant has been medically cleared to participate in physical activity.

• Participant verbalizes understanding of directions for use of the web-based platform on the study provided iPad and heart rate monitor.

Locations
United States
Tennessee
St. Jude Children's Research Hospital
RECRUITING
Memphis
Contact Information
Primary
Amy Berkman, MD
referralinfo@stjude.org
888-226-4343
Time Frame
Start Date: 2026-06-08
Estimated Completion Date: 2029-01
Participants
Target number of participants: 20
Treatments
Experimental: HIIT Intervention Group
Participants will complete a 12-week HIIT program with three 25-minute sessions per week. Each session includes warm-up, five cycles of high-intensity intervals (80-95% peak HR) and recovery periods (50-60% peak HR), and cool-down.
Related Therapeutic Areas
Sponsors
Leads: St. Jude Children's Research Hospital

This content was sourced from clinicaltrials.gov